Lucira Health, Inc. (LHDX) Misses Q3 EPS by 277c

Lucira Health, Inc. (NASDAQ: LHDX) reported Q3 EPS of ($3.15), $2.77 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $34.4 million versus the consensus estimate of $33.33 million.

For earnings history and earnings-related data on Lucira Health, Inc. (LHDX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
• Investing.com’s stocks of the week